DRWF accepts research applications related to finding the cause, prevention, treatment, and cure of diabetes and its complications. The maximum support of these grants is up to $50,000 per year for up to 2 years. If the proposed research is within an area of primary interest and is judged as having high scientific merit by the Foundation’s advisors, the Board of Directors may make special grant awards that exceed the stated maximum. Currently, the Foundation’s area of primary interest and focus are islet cell transplantation, macrovascular disease & neuropathy. All other research proposals will not be reviewed.
Research proposals are evaluated along the following parameters:
Human subjects participating in research supported by DRWF must give their prior legally acceptable and informed consent.
A blank copy of the consent form used should accompany the application. The care and treatment of human and animal subjects should be in compliance with NIH guidelines.
A written progress report describing the accomplishments and or findings of the project is due 3 months after completion of the project or 1 year after the receipt of funds, whichever comes first.
Publications and presentations resulting from research funded in whole or in part by DRWF shall contain this acknowledgment: "Supported by a grant from Diabetes Research and Wellness Foundation." A reprint of any article or publication carrying this acknowledgment shall be provided to DRWF.
Program Grants
DRWF awards a limited number of program grants, the amount of which is based on available funds. The program must be educational or community health oriented, and targeted to people with diabetes or health professionals working in the field of diabetes.
Proposals
All proposals submitted to DRWF must be prepared as outlined below.
1. Direct relevance to diabetes — with special emphasis on DRWF’s priority areas
DRWF supports research aimed at “the cause, prevention, treatment, and cure of diabetes and its complications.”
Currently, DRWF’s stated areas of primary interest are islet cell transplantation, macrovascular disease, and neuropathy.
Proposals outside those themes typically are not reviewed.
Predictor: The closer and more explicitly your project connects to diabetes — especially to islet biology, vascular complications, or neuropathy — the more competitive it is.
2. Hypothesis-driven research with a well-defined plan
DRWF requires a clear structure: Specific Aims, Significance, Methodology & Timetable, Budget, Ethical oversight (if human/animal subjects) in the application.
Projects should include a realistic methodology and timetable because funding is modest (up to US $50,000/year for up to 2 years).
Predictor: A concise, focused proposal with a realistic timeline and clear experimental plan is strongly favored.
3. Scientific merit & feasibility
Review criteria explicitly include “scientific merit” and “qualifications and experience of investigators”.
Projects that clearly demonstrate feasibility — either via preliminary data or a strong rationale with achievable experiments — stand out.
Predictor: Demonstrable feasibility and strong scientific rationale substantially increase chances of funding.
4. Appropriate use of funds and reasonable budget
DRWF limits indirect costs — their grant guidelines allow indirect costs less than 10% per year.
Budget should be well justified, with clear description of supplies, personnel effort, fringe, etc.
Predictor: Lean, well-justified budgets aligned with project scope are viewed favorably, particularly because DRWF is a moderate-sized funder.
5. Realistic deliverables and milestones
Given the size and duration of grants, reviewers expect realistic outputs within 1–2 years (or total 2 years).
The project narrative (methodology & timetable section) must show what will be accomplished, when, and how.
Predictor: Well-defined deliverables — not open-ended exploration — improve reviewer confidence.
6. Investigator commitment and expertise
Reviewers consider the investigator’s track record — prior publications, relevant experience, and institutional support.
For translational or clinically relevant proposals (e.g., islet cell transplantation, vascular complications), having access to the right infrastructure, collaborators, or patient/sample resources is important.
Predictor: Strong investigator profile + institutional capacity for execution enhances competitiveness.
7. Ethical compliance and proper oversight for human/animal studies
If research involves human or animal subjects, ethical consent or approval (e.g., IRB/IACUC) must be included / assured.
For human-subject research, informed consent must be obtained and documented.
Predictor: Clear, ethical compliance plans are mandatory — lacking or vague plans likely lead to rejection.
8. Alignment with long-term diabetes research goals — toward treatment, prevention, or cure
While DRWF supports various diabetes research, its mission emphasizes finding a cure or improving long-term outcomes for people with diabetes.
Projects focusing on islet cell replacement, preventing vascular or neuropathic complications, improving transplant outcomes or long-term disease burden reduction align closely with the Foundation’s mission.
Predictor: Projects that clearly situate themselves as part of the “path toward cure or major improvement” tend to garner stronger support.
9. Clarity, organization, and following DRWF application guidelines strictly
The application must include a completed cover sheet, one-page abstract, project narrative (max 8 pages covering aims, significance, methodology, timetable), ethical statements, budget, etc.
Proposals must be concise, clear, and well-structured so reviewers can quickly assess aims, feasibility, and potential impact.
Predictor: Well-written, guideline-compliant proposals perform better than equivalent science poorly communicated.
Projects outside the Foundation’s priority focus (islet transplantation, vascular complications, neuropathy) may not even be reviewed.
Over-ambitious scope — unrealistic aims or too many aims for a small grant — tends to be penalized.
Poor or missing ethical oversight (consent, IRB/IACUC) for human/animal research.
Weak budget justification or excessive indirect costs.
Lack of feasibility or vague methodologies.
Investigator without sufficient background in diabetes research, or without access to necessary resources or collaborators.
If you propose a project, consider the following to maximize your chances:
Align tightly with DRWF’s priority themes — islet biology, vascular disease, neuropathy, or other high-burden diabetes complications.
Present a focused, achievable 2- or 3-aim plan, scoped for 1–2 years.
Provide pilot data or very strong rationale to support feasibility.
Build a lean and justified budget; avoid unnecessary costs or high overheads.
Demonstrate ethical compliance for any human/animal work.
Highlight investigator expertise, institutional support, and access to needed resources (cells, patient samples, animal models, etc.).
Emphasize how your project contributes to long-term goals: better treatments, complication prevention, or diabetes cure.
Write clearly, follow DRWF’s application format carefully, and make your significance and aims obvious to non-specialist reviewers.
Research proposals are evaluated along the following parameters:
Sponsor Institute/Organizations: Diabetes Research and Wellness Foundation (U.S.)
Sponsor Type: Corporate/Non-Profit
Address: 7220 Wisconsin Avenue Suite 210, Bethesda, MD 20814
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Dec 30, 2025
Dec 30, 2025
$50,000
Affiliation: Diabetes Research and Wellness Foundation (U.S.)
Address: 7220 Wisconsin Avenue Suite 210, Bethesda, MD 20814
Website URL: https://www.diabeteswellness.net/apply-funding
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.